Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual-hormone (Insulin-pramlintide) Closed-loop Delivery in Type 1 Diabetes
NCT03800875Phase 2Completed
- Sponsor
- McGill University
- Start
- Feb 2019
- Primary completion
- Sep 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of pramlintide in type 1 diabetes mellitus (T1D), sponsored by McGill University. Started Feb 2019; status: completed.
02
Drugs
pramlintide
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03800875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03800875.